Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/1997
02/06/1997WO1997004075A1 Pharmaceutical compositions containing tsg-6 for treating inflammatory diseases and cancer-related pathologies and methods
02/06/1997WO1997004010A1 SIGNAL TRANSDUCTION AGENTS OF T-CELL RECEPTOR Vα-1 GENE LOCUS
02/06/1997WO1997004009A1 Colostrum derived growth factor
02/06/1997WO1997004008A1 Anti-fungal peptides
02/06/1997WO1997004007A2 Metal-containing ribonucleotide polypeptides
02/06/1997WO1997004006A1 Substance for use against tumour growth and viral infections
02/06/1997WO1997004004A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES
02/06/1997WO1997004003A2 Process for protein refolding by means of buffer exchange using a continuous stationary phase capable of separating proteins from salts
02/06/1997WO1997004000A1 Hepadnavirus receptor
02/06/1997WO1997003999A1 Mutant s182 genes
02/06/1997WO1997003998A1 Modulators of the function of fas receptors and other proteins
02/06/1997WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
02/06/1997WO1997003701A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
02/06/1997WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
02/06/1997WO1997003694A1 Remedy for viral diseases
02/06/1997WO1997003691A1 Methods of treatment of neurological diseases by interferon antagonists
02/06/1997WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE
02/06/1997WO1997003681A1 Methods for selectively killing or inhibiting the growth of cells expressing the waf1 gene
02/06/1997WO1997003635A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY
02/06/1997WO1997003555A1 Transgenic animal model of osteopenia
02/06/1997WO1996040926A3 Detection of cryptosporidium parvum
02/06/1997WO1996040924A3 Cotton fiber transcriptional factors
02/06/1997WO1996040770A3 Anti-fungal d-amino acid histatin-based peptides
02/06/1997WO1996040766A3 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
02/06/1997WO1996040763A3 Peptides for hiv-1 detection
02/06/1997WO1996040760A3 Iodine-containing peptides and their use as x-ray contrast media
02/06/1997DE19540515C1 Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten Tumor therapy by adoptive transfer CD44v-specific cytotoxic T lymphocytes
02/06/1997DE19528544A1 cDNA-Sequenz und daraus abgeleitete Aminosäuresequenz des Vorläuferproteins von humanem GCAP II/Uroguanylin sowie Aminosäuresequenz des im humanen Blut zirkulierenden Fragmentes cDNA sequence and deduced amino acid sequence of the precursor protein of human GCAP II / uroguanylin and amino acid sequence of the human blood circulating in the fragment
02/06/1997CA2227554A1 Nucleic sequences coding for melatonin receptors, and uses thereof
02/06/1997CA2227537A1 Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody
02/06/1997CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease
02/06/1997CA2227441A1 Hepadvavirus receptor
02/06/1997CA2227370A1 Methods for selectively killing or inhibiting the growth of cells expressing the waf1 gene
02/06/1997CA2227339A1 Synthetic hpv11 virus-like particles
02/06/1997CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
02/06/1997CA2227292A1 Anti-fungal peptides
02/06/1997CA2227277A1 Porphyrin-accumulating type herbicide resistance gene
02/06/1997CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins
02/06/1997CA2227198A1 Cysteine protease inhibitors for use in treatment of ige mediated allergic diseases
02/06/1997CA2227193A1 P16 expression constructs and their application in cancer therapy
02/06/1997CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
02/06/1997CA2227035A1 Cd4 gene regulatory sequences specifically expressed in mature t cells
02/06/1997CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins
02/06/1997CA2227013A1 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
02/06/1997CA2226926A1 Liver-specific adenovirus expression vector
02/06/1997CA2226911A1 Methods of treatment of neurological diseases by interferon antagonists
02/06/1997CA2226872A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis
02/06/1997CA2224289A1 New protein hmw human mp52s
02/06/1997CA2196802A1 Metal-containing ribonucleotide polypeptides
02/05/1997EP0757099A2 CTLA4 mutant molecules and uses thereof
02/05/1997EP0756708A1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation
02/05/1997EP0756638A1 Method and means for detecting and treating disorders in the blood coagulation cascade
02/05/1997EP0756630A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
02/05/1997EP0756629A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
02/05/1997EP0756628A1 Morphogenic protein-specific cell surface receptors and uses therefor
02/05/1997EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
02/05/1997EP0756626A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines
02/05/1997EP0756605A1 Peptides as therapeutic agents for the treatment of auto-immune diseases
02/05/1997EP0756604A1 Melanoma antigens
02/05/1997EP0756603A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
02/05/1997EP0756494A1 Modified insulin-like growth factors
02/05/1997EP0756490A1 Human bone stimulating factor
02/05/1997EP0756488A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
02/05/1997EP0756487A1 Method for implanting encapsulated cells in a host
02/05/1997EP0756449A1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
02/05/1997EP0652895A4 Compounds which inhibit hiv replication.
02/05/1997EP0616642B1 New thrombin-inhibiting proteins from terrestrial leeches
02/05/1997EP0573499B1 Process for the phosphorylation of insulin and product produced thereby
02/05/1997CN1142247A Extracorporeal ceel culture and transplantation kits
02/05/1997CN1142231A Abundant extracellular products and methods for production and use of same
02/05/1997CN1142230A Antibiotic stalobacins
02/05/1997CN1142229A Peptide sequence that forms mucin sugar chain and technique for modifying protein tob e linked with mucin sugar chain
02/05/1997CN1142188A 人生长激素 Human Growth Hormone
02/05/1997CN1142187A Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament
02/05/1997CN1141952A Carotenoid production by fermentation
02/05/1997CN1141809A Method for treatment of undissolved thrombus acute myocardinal infraction by using hirudin and acetylsalicylic acid
02/05/1997CN1141808A Interferon solution
02/05/1997CN1033976C Preparation of polypeptides used as blockers of calcium channels
02/04/1997US5599920 Dna sequences
02/04/1997US5599919 Nucleic acid encoding a transiently-expressed kinetochore protein, and methods of use
02/04/1997US5599918 Nucleic acids encoding trophinin and trophinin-assisting proteins
02/04/1997US5599914 Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof
02/04/1997US5599912 Compounds and methods for suppressing an immune response to sulfomethoxozale containing substances
02/04/1997US5599909 Process for reactivating purified membrane proteins
02/04/1997US5599907 Production and use of multimeric hemoglobins
02/04/1997US5599906 Hybrid regulatory proteins capable of binding to a specific region of dna that controls expression of indicator genes
02/04/1997US5599905 Interleukin-4 receptors
02/04/1997US5599904 Encoded by dna carried on plsmid; glucocorticoid/mineralocorticoid/thyroid hormone/retinoic acid and estrogen related receptors
02/04/1997US5599901 Oligopeptides useful as affinity chromatography supports for the separation and purification of proteins; variable charge distribution, hydrophobicity, molecular rigidity and helical conformation propensity
02/04/1997US5599844 Administering agent to elevate level of transforming growth factor beta
02/04/1997US5599831 Converting amphipathic drug to lipophilic derivative capable of reconversion by lysosomal enzymes, combining with lipophilic carrier
02/04/1997US5599792 Bone-stimulating, non-vasoactive parathyroid hormone variants
02/04/1997US5599791 Bactericide active against gramnegative and grampositive bacteria
02/04/1997US5599790 Fibrinogen γ chain polypeptide and compositions thereof
02/04/1997US5599788 Wound healing agents; dermal fibroplast adhesion promoter
02/04/1997US5599719 Method for isolating biomolecules from a biological sample with linear polymers
02/04/1997US5599709 Recombinant DNA encoding neuronal α-bungarotoxin-binding proteins
02/04/1997US5599708 Stimulate formation of osteoclast bone cells; treatment of bone marrow disorders
02/04/1997US5599707 Human prohibitin DNA
02/04/1997US5599701 Inositol-excreting yeast